Guidance on GxP data integrity
The document provides guidance on the data integrity expectations that should be considered by organisations involved in any aspect of the pharmaceutical lifecycle or GLP studies regulated by MHRA.
Read the news from Medicines and Healthcare products Regulatory Agency updated on 27 September 2021.
OpenEdition vous propose de citer ce billet de la manière suivante :
lsgilbert (14 mars 2022). Guidance on GxP data integrity. ELSIBI. Consulté le 16 mars 2026 à l’adresse https://doi.org/10.58079/o5v0





